Market Access What India can learn from Kinvard Bio India needs its own version of pull, designed for an Indian payer mix, an Indian procurement structure, and an Indian distributor network.
Market Access Industry exercises option for midpoint review of VPAG Invest... Under the VPAG agreement, £400 million is available under the VPAG Investment Fund. But what benefits will stay once funding goes away in 2029?
News Philanthropic drive puts $140m behind strep A vaccine A $140m fund launched by philanthropic group Coefficient Giving will try to find the first vaccine for Strep A, which kills 639,000 people a year.
Market Access JPM 2026: What it revealed about biotech’s new reality JPM 2026 signalled genuine recovery – but not the kind the industry has historically celebrated.
News Five projects share £100m UK-US Cancer Grand Challenges fund Five scientific teams will receive up to £20m each in a new round of funding under the UK and US Cancer Grand Challenges initiative.
News US checks out of WHO, leaving its bill unsettled A year after President Trump signed an order for the US to withdraw from the WHO, the exit is taking place today, with $260m in fees left unpaid.
News Ionis claims first approval for Alexander disease therapy Ionis' Zanvastro has been approved by the FDA for Alexander disease, becoming the first disease-modifying therapy for the devastating rare disease.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.